Cargando…
Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues
Lipid nanoparticles (LNPs) for delivery of mRNA usually contain ionizable lipid/helper lipid/cholesterol/PEG-lipid in molar ratios of 50:10:38.5:1.5, respectively. These LNPs are rapidly cleared from the circulation following intravenous (i.v.) administration, limiting uptake into other tissues. Her...
Autores principales: | Chander, Nisha, Basha, Genc, Yan Cheng, Miffy Hok, Witzigmann, Dominik, Cullis, Pieter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410000/ https://www.ncbi.nlm.nih.gov/pubmed/37564393 http://dx.doi.org/10.1016/j.omtm.2023.06.005 |
Ejemplares similares
-
Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
por: Pattipeiluhu, Roy, et al.
Publicado: (2022) -
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures
por: Meulewaeter, Sofie, et al.
Publicado: (2023) -
Lipid nanoparticle technology for therapeutic gene regulation in the liver
por: Witzigmann, Dominik, et al.
Publicado: (2020) -
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency
por: Thurberg, Beth L., et al.
Publicado: (2016) -
Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
por: Basha, Genc, et al.
Publicado: (2016)